Abstract
The Certificate of Analysis (CoA) is a crucial Good Manufacturing Practice (GMP) document for a batch of drug substances or products in development or production. It contains essential quality information and a summary of specifications and testing results. This article describes the contents and associated calculations of CoAs for small-molecule drugs. It explains how these documents help to ensure drug quality in the supply chain.
Publisher
Multimedia Pharma Sciences, LLC